Invesco
ONCT

Invesco’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Invesco’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-609
Closed -$17K – 4190
2022
Q1 		$17K Sell
609
-14
-2% -$510 ﹤0.01% 3993
2021
Q4 		$28K Sell
623
-72
-10% -$4.84K ﹤0.01% 4015
2021
Q3 		$58K Buy
695
+118
+20% +$9.76K ﹤0.01% 3995
2021
Q2 		$55K Sell
577
-47,320
-99% -$5.62M ﹤0.01% 3947
2021
Q1 		$7.97M Buy
+47,897
New +$6.33M ﹤0.01% 2096
2018
Q3 		– Sell
-1,295
Closed -$2.77M – 3944
2018
Q2 		$2.77M Buy
+1,295
New +$3.28M ﹤0.01% 2537

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $1.79B AUM 157.17% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return